Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
Jan. 31, 2021
Apr. 30, 2020
Current Assets    
Cash $ 471,652 $ 236,668
Accounts Receivable, net 312,414
Inventory 708,017 78,650
Other 505,865 3,020
Total Current Assets 1,997,948 318,338
Goodwill 9,449,333 2,466,073
Intangible assets, net 631,429 20,000
Other 3,853 3,853
TOTAL ASSETS 12,082,563 2,808,264
Current Liabilities    
Accounts payable 873,312 249,050
Accrued Expenses 209,804 89,342
Notes Payable 177,279 118,771
Due to Related Party 395,544 333,684
Customer deposits 96,580 38,419
Derivative liability 9,144,226
Total Current Liabilities 10,896,745 829,266
Convertible debentures, net 79,187 450,000
Due to Related Party 1,753,000
Total Long Term Liabilities 1,832,187 450,000
Commitments and contingencies
Stockholders' Equity    
Series A Preferred Stock - shares authorized 2,200,000; outstanding 158,704 and 208,704; Series B Preferred Stock - shares authorized 4,300,000; outstanding 2,726,882 and 3,681,623 28,856 38,903
Common stock - shares authorized 500,000,000; outstanding 27,160,926 and 20,011,091 27,161 20,011
Additional paid-in capital 11,961,152 4,043,837
Accumulated deficit (12,663,538) (2,573,753)
Total Stockholders' Equity (646,369) 1,528,998
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 12,082,563 $ 2,808,264